CLA Fundamental Analysis - CLARANOVA SE

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to CLA. CLA was compared to 107 industry peers in the Software industry. CLA has a medium profitability rating, but doesn't score so well on its financial health evaluation. CLA has a bad growth rate and is valued cheaply.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CLA has reported negative net income.

CLA had a positive operating cash flow in the past year.

In multiple years CLA reported negative net income over the last 5 years.

In the past 5 years CLA always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of -1.14%, CLA perfoms like the industry average, outperforming 42.06% of the companies in the same industry.

CLA had an Average Return On Invested Capital over the past 3 years of 17.26%. This is above the industry average of 12.55%.

The last Return On Invested Capital (%ROIC%%) for CLA is well below the 3 year average (17.26%), which needs to be investigated, but indicates that CLA had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	-1.14%
ROE	N/A
ROIC	N/A

ROA(3y)-4.27%

ROA(5y)-1.67%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)17.26%

ROIC(5y)13.84%

1.3 Margins

With a Operating Margin value of 8.86%, CLA perfoms like the industry average, outperforming 58.88% of the companies in the same industry.

In the last couple of years the Operating Margin of CLA has grown nicely.

CLA has a worse Gross Margin (29.19%) than 80.37% of its industry peers.

In the last couple of years the Gross Margin of CLA has grown nicely.

		Industry Rank	Sector Rank
OM	8.86%
PM (TTM)	N/A
GM	29.19%

OM growth 3Y14.65%

OM growth 5Y11.6%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.23%

GM growth 5Y1.62%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CLA has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.

The number of shares outstanding for CLA has been increased compared to 1 year ago.

CLA has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, CLA has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.61, we must say that CLA is in the distress zone and has some risk of bankruptcy.

CLA has a Altman-Z score of 0.61. This is amonst the worse of the industry: CLA underperforms 80.37% of its industry peers.

The Debt to FCF ratio of CLA is 5.38, which is a neutral value as it means it would take CLA, 5.38 years of fcf income to pay off all of its debts.

The Debt to FCF ratio of CLA (5.38) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	5.38
Altman-Z	0.61

ROIC/WACCN/A

WACC7.82%

2.3 Liquidity

A Current Ratio of 0.50 indicates that CLA may have some problems paying its short term obligations.

CLA has a Current ratio of 0.50. This is amonst the worse of the industry: CLA underperforms 87.85% of its industry peers.

A Quick Ratio of 0.45 indicates that CLA may have some problems paying its short term obligations.

CLA has a Quick ratio of 0.45. This is amonst the worse of the industry: CLA underperforms 88.78% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.5
Quick Ratio	0.45

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.81% over the past year.

CLA shows a decrease in Revenue. In the last year, the revenue decreased by -0.95%.

Measured over the past years, CLA shows a quite strong growth in Revenue. The Revenue has been growing by 13.58% on average per year.

EPS 1Y (TTM)34.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%497.85%

Revenue 1Y (TTM)-0.95%

Revenue growth 3Y1.74%

Revenue growth 5Y13.58%

Sales Q2Q%-2.36%

3.2 Future

CLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.54% yearly.

Based on estimates for the next years, CLA will show a very negative growth in Revenue. The Revenue will decrease by -36.77% on average per year.

EPS Next Y84.24%

EPS Next 2Y59.54%

EPS Next 3Y43.54%

EPS Next 5YN/A

Revenue Next Year-76.76%

Revenue Next 2Y-51.01%

Revenue Next 3Y-36.77%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

With a Price/Forward Earnings ratio of 4.88, the valuation of CLA can be described as very cheap.

Based on the Price/Forward Earnings ratio, CLA is valued cheaply inside the industry as 98.13% of the companies are valued more expensively.

CLA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.87.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.88

4.2 Price Multiples

99.07% of the companies in the same industry are more expensive than CLA, based on the Enterprise Value to EBITDA ratio.

Based on the Price/Free Cash Flow ratio, CLA is valued cheaply inside the industry as 99.07% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	3.28
EV/EBITDA	2.88

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

CLA's earnings are expected to grow with 43.54% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y59.54%

EPS Next 3Y43.54%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CLA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CLARANOVA SE

EPA:CLA (9/23/2025, 7:00:00 PM)

1.726

+0.06 (+3.85%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)05-13 2025-05-13

Earnings (Next)10-29 2025-10-29/amc

Inst Owners4.7%

Inst Owner ChangeN/A

Ins Owners5.02%

Ins Owner ChangeN/A

Market Cap98.74M

Analysts80

Price Target3.52 (103.94%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-6.76%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-2.57%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-61.7%

Revenue NY rev (3m)-76.33%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.88
P/S	0.2
P/FCF	3.28
P/OCF	2.68
P/B	N/A
P/tB	N/A
EV/EBITDA	2.88

EPS(TTM)-0.08

EYN/A

EPS(NY)0.35

Fwd EY20.48%

FCF(TTM)0.53

FCFY30.48%

OCF(TTM)0.64

OCFY37.37%

SpS8.54

BVpS-0.3

TBVpS-2.29

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.14%
ROE	N/A
ROCE	-2165%
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	8.86%
PM (TTM)	N/A
GM	29.19%
FCFM	6.16%

ROA(3y)-4.27%

ROA(5y)-1.67%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)17.26%

ROIC(5y)13.84%

ROICexc(3y)46.34%

ROICexc(5y)36.95%

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)23.49%

ROCE(5y)18.83%

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3Y3.39%

ROICexc growth 5Y10.18%

OM growth 3Y14.65%

OM growth 5Y11.6%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.23%

GM growth 5Y1.62%

F-Score7

Asset Turnover1.69

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	5.38
Debt/EBITDA	0.21
Cap/Depr	55.74%
Cap/Sales	1.39%
Interest Coverage	250
Cash Conversion	66.49%
Profit Quality	N/A
Current Ratio	0.5
Quick Ratio	0.45
Altman-Z	0.61

F-Score7

WACC7.82%

ROIC/WACCN/A

Cap/Depr(3y)51.75%

Cap/Depr(5y)41.72%

Cap/Sales(3y)1.22%

Cap/Sales(5y)0.95%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)34.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%497.85%

EPS Next Y84.24%

EPS Next 2Y59.54%

EPS Next 3Y43.54%

EPS Next 5YN/A

Revenue 1Y (TTM)-0.95%

Revenue growth 3Y1.74%

Revenue growth 5Y13.58%

Sales Q2Q%-2.36%

Revenue Next Year-76.76%

Revenue Next 2Y-51.01%

Revenue Next 3Y-36.77%

Revenue Next 5YN/A

EBIT growth 1Y22.32%

EBIT growth 3Y16.65%

EBIT growth 5Y26.75%

EBIT Next Year25.23%

EBIT Next 3Y14.42%

EBIT Next 5YN/A

FCF growth 1Y323.94%

FCF growth 3Y32.3%

FCF growth 5Y48.99%

OCF growth 1Y212.71%

OCF growth 3Y28.52%

OCF growth 5Y40.7%

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens